Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes August 2000 49:1325-1333; doi:10.2337/diabetes.49.8.1325
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia
and hypertrophy. Diabetes August 2000 49:1341-1346; doi:10.2337/diabetes.49.8.1341
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes August 2000 49:1353-1358; doi:10.2337/diabetes.49.8.1353
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes August 2000 49:1325-1333; doi:10.2337/diabetes.49.8.1325
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes August 2000 49:1288-1294; doi:10.2337/diabetes.49.8.1288
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes August 2000 49:1353-1358; doi:10.2337/diabetes.49.8.1353
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes August 2000 49:1325-1333; doi:10.2337/diabetes.49.8.1325
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes August 2000 49:1353-1358; doi:10.2337/diabetes.49.8.1353
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia
and hypertrophy. Diabetes August 2000 49:1341-1346; doi:10.2337/diabetes.49.8.1341
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia
and hypertrophy. Diabetes August 2000 49:1341-1346; doi:10.2337/diabetes.49.8.1341
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes August 2000 49:1353-1358; doi:10.2337/diabetes.49.8.1353
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic
patients. Diabetes August 2000 49:1390-1393; doi:10.2337/diabetes.49.8.1390
Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes August 2000 49:1288-1294; doi:10.2337/diabetes.49.8.1288
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes August 2000 49:1325-1333; doi:10.2337/diabetes.49.8.1325
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes
Prediction and Prevention Study. Diabetes August 2000 49:1314-1318; doi:10.2337/diabetes.49.8.1314
Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia
and hypertrophy. Diabetes August 2000 49:1341-1346; doi:10.2337/diabetes.49.8.1341
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
Diabetes August 2000 49:1319-1324; doi:10.2337/diabetes.49.8.1319
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes August 2000 49:1359-1366; doi:10.2337/diabetes.49.8.1359
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes August 2000 49:1325-1333; doi:10.2337/diabetes.49.8.1325
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes August 2000 49:1367-1373; doi:10.2337/diabetes.49.8.1367
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes August 2000 49:1347-1352; doi:10.2337/diabetes.49.8.1347
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
Diabetes August 2000 49:1334-1340; doi:10.2337/diabetes.49.8.1334
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue
during morbid obesity. Diabetes August 2000 49:1374-1380; doi:10.2337/diabetes.49.8.1374
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes August 2000 49:1281-1287; doi:10.2337/diabetes.49.8.1281
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes August 2000 49:1353-1358; doi:10.2337/diabetes.49.8.1353